News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory news - March 2021Regulatory news - March 2021March newsletter: UK attractiveness for ATMP companies to expand their operationsMarch newsletter: UK attractiveness for ATMP companies to expand their operationsNational Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN)National Horizons Centre expands as National Training Centre for the Advanced Therapies Skills Training Network (ATSTN)April news: The UK attractiveness for companies to expand their ATMP operationsApril news: The UK attractiveness for companies to expand their ATMP operationsPress release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenagePress release: GSK expands its clinical trial manufacturing capacity for cell and gene therapy at the Cell and Gene Therapy Catapult facility in StevenageRegulatory news - February 2021Regulatory news - February 2021Press release: 2020 clinical trials database report confirms the UK as an internationally attractive clinical space for the development of cell and gene therapiesPress release: 2020 clinical trials database report confirms the UK as an internationally attractive clinical space for the development of cell and gene therapiesPress release: Cell and Gene Therapy Catapult appoints Dr. Ian Campbell as Innovate UK nominated non-executive DirectorPress release: Cell and Gene Therapy Catapult appoints Dr. Ian Campbell as Innovate UK nominated non-executive DirectorPress release: Rentschler Biopharma to build new cell and gene therapy capabilities in the UKPress release: Rentschler Biopharma to build new cell and gene therapy capabilities in the UKRegulatory News - January 2021Regulatory News - January 2021CGT Catapult’s third annual clinical adoption workshop offers recommendations for advancing institutional readiness across the NHS to accelerate the routine adoption of cell and gene therapiesCGT Catapult’s third annual clinical adoption workshop offers recommendations for advancing institutional readiness across the NHS to accelerate the routine adoption of cell and gene therapiesFebruary news: The UK's attractiveness for manufacturing ATMPsFebruary news: The UK's attractiveness for manufacturing ATMPs